Related Experiment Video
Updated: Sep 17, 2025

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry
Published on: December 26, 2019
Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective
Amir A Toor1, Morgan Horton2, Haniya Khalid2
1Harold C. Simmons Cancer Center, University of Texas Southwestern, Dallas, Texas.
Donor telomere length shortening after hematopoietic cell transplantation (HCT) impacts patient survival. Intermediate telomere length shortening predicts better outcomes, while minimal or maximal shortening indicates worse overall survival (OS).
Area of Science:
- Genetics and Genomics
- Immunology
- Transplantation Biology
Background:
- Hematopoietic cell transplantation (HCT) success relies on T cell proliferation and repertoire reconstitution.
- Telomere length (TL) is a potential marker for T cell proliferative capacity, but average leukocyte TL overlooks variations within cell populations.
- A novel method is needed to analyze the full spectrum of TL for better prediction of HCT outcomes.
Purpose of the Study:
- To develop and validate a method integrating the entire spectrum of telomere lengths (TL) within a sample.
- To assess the influence of this comprehensive TL analysis on clinical outcomes following HCT.
- To correlate donor T cell telomere attrition with patient survival post-transplant.
Main Methods:
- Utilized Telomere Shortest Length Assay (TeSLA) for discrete TL measurements from 72 paired donor and recipient samples.
- Calculated the Area Under the Curve (AUC) for leukocyte TL (LTL) distributions to represent the full spectrum of TL.
- Defined AUC delta-TL as the magnitude of LTL shortening post-HCT to analyze clinical outcome correlations.
Main Results:
- Telomere band lengths exhibited a wide range (350 bp to 16.7 kb) with a logarithmically declining distribution.
- AUC delta-TL significantly predicted overall survival (OS; P < .0001).
- Intermediate TL shortening (25th-75th percentile) correlated with the best 2-year OS (92%), while minimal (<25th) and maximal (>75th) shortening showed significantly worse outcomes (33% and 59% OS, respectively).
Conclusions:
- The degree of donor telomere attrition, analyzed across the entire TL spectrum, correlates with clinical outcomes post-HCT.
- This comprehensive TL analysis may better identify patient risk groups following transplantation.
- Telomere shortening dynamics could reflect alloreactive T cell expansion and influence HCT success.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Telomeres and Telomerase
Hematopoiesis
Replicative Cell Senescence
Multipotency of Hematopoietic Stem Cells
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...

